Loading
Overweight and Obesity / Pecan / Nutrition, Healthy · Interventional Study
ClinicalTrials.gov · August 11, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registered but not-yet-recruiting interventional trial designed to examine the effect of pecan consumption at 6% of total daily energy intake over 12 weeks on fasting and postprandial blood lipids and markers of chronic disease risk in a sample of 90 participants. No results are available in this registry record.
Interventional, Randomized, Parallel, Single masking, Prevention purpose. Nutrition, Healthy, Dyslipidemia, Overweight and Obesity; age from 25 Years; to 75 Years; accepts healthy volunteers. Intervention: Pecan; Control. Compared with: Habitual diet (control). n = 90. 1 site: United States.
This is a registered but not-yet-recruiting interventional trial designed to examine the effect of pecan consumption at 6% of total daily energy intake over 12 weeks on fasting and postprandial blood lipids and markers of chronic disease risk in a sample of 90 participants. No results are available in this registry record.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This trial addresses whether a modest pecan intake affects lipid metabolism and cardiometabolic markers. Results, when available, may inform dietary recommendations for cardiovascular risk reduction, but the small sample and surrogate endpoints mean impact will depend on magnitude and consistency with future studies.
This is a study registration for a planned interventional trial with no results posted; the design is sound but enrollment is not yet complete and no outcomes have been reported.
As stated by the source record.
Quoted from the source exactly as published.
This trial addresses whether a modest pecan intake affects lipid metabolism and cardiometabolic markers. Results, when available, may inform dietary recommendations for cardiovascular risk reduction, but the small sample and surrogate endpoints mean impact will depend on magnitude and consistency with future studies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07696403). This is a study registration, not published results. Lead sponsor: University of Georgia. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 90 participants (ESTIMATED). Conditions: Nutrition, Healthy, Dyslipidemia, Overweight and Obesity. Interventions: OTHER: Pecan; OTHER: Control. Primary outcome measures: Change in fasting serum lipoprotein and cholesterol concentrations , baseline, 12 weeks; Change in fasting and postprandial plasma lipid concentrations , baseline, 12 weeks. Brief summary: Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, folic acid, calcium, magnesium, phosphorus, potassium, and zinc. These bioactive components in pecans are likely the reason for the previously documented improvements in cardiometabolic health. This study aims to examine the impact of a low dose of pecans on changes in fasting and postprandial lipid metabolism/blood lipids and markers of chronic disease risk. The specific aims of this study are to: * Examine the effect of pecan consumption at a dose of 6% of total energy needs for 12 weeks on fasting and postprandial blood lipids. * Examine the effect of pecan consumption at a dose of 6% of total energy needs for 12 weeks on other markers of chronic disease risk. Participants will be asked to: * Consume pecans daily for 12 weeks or maintain their current habitual diet. * Attend two short visits at 4 and 8 weeks for fasting blood draws, body measurements, and to collect their next 4 weeks' supply of study materials. * Attend two longer (5 h) testing visits, which include eating a standard breakfast meal and having their blood drawn periodically before and after breakfast. Researchers will compare the Pecan and Control groups to examine the physiologic effects of incorporating a low dose of pecans into one's diet.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.